BioWorld MedTech

April 2, 2012

Corindus meets primary endpoints for PRECISE trial

Corindus Vascular Robotics (Natick, Massachusetts) reported it has met the primary endpoints for its PRECISE trial and results indicate the Corpath 200 System could be considered as a safer alternative to manual PCI. Read More

Trust thy lender, but pay heed to thine term sheet

Report from Europe: Abbott gains CE mark for PLEX-ID System

Washington roundup: NHS wants multi-disciplinary team for aortic valve implants

Deals roundup: HeartWare to acquire WorldHeart for $8M

MDD's Fun Facts

Financings roundup: HIT Application Solutions secures $2.75M for Notifi

HIT roundup: Lovelace selects ZeOmega Jive for integrated care

Agreements/contracts: Accuray in collaboration pact with U. of Heidelberg

Restructuring roundup: HR to lay off 3% of workforce to deal with med-device tax

Product Briefs

St. Jude pulls Brio DBS off European market

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...